I-Corps @ NIH
|
Training Initiative
|
CDC
|
NCATS, NCCIH, NCI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIMH, NINDS
|
2015
|
|
IAA with FDA - Using big data to compare SARS-CoV-2 infection and therapeutic efficacy between human lung on a chip and animal model testing
|
Resource Development
|
FDA
|
NIAID
|
2020
|
|
ICCVAM Ecotoxicology Workgroup (EcoWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIEHS
|
2018
|
|
ICCVAM In Vitro to In Vivo Extrapolation Workgroup (IVIVE-WG)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA
|
NIEHS, NLM
|
2017
|
|
ICCVAM Metrics Workgroup (MWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIEHS, OD
|
2019
|
|
ICCVAM Nanomaterials Workgroup (NanoWG)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
NIEHS
|
2018
|
|
ICCVAM Public Forum
|
Meeting/ Workshop
|
FDA
|
NCATS, NIEHS
|
2014
|
|
ICCVAM Read Across Workgroup (RAWG)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA
|
NIEHS, NLM
|
2017
|
|
Image-guided Interventional Therapeutics
|
Research Initiative
|
FDA
|
CC, NCI
|
2004
|
|
Immunology Interest Group
|
Meeting/ Workshop
|
FDA
|
NIDDK, NCI, NHLBI, NIAID, NINDS, NIEHS, CC, NIAMS, NEI, NIDCR, NICHD, NIAAA, NIMH, NHGRI
|
1990
|
|
Implementation Research in HRSA Ryan White Sites: Screening and Treatment for Mental and Substance Use Disorders to Further the National “Ending the HIV Epidemic” (EHE) Goals
|
Research Initiative
|
HRSA
|
NIDA, NIMH
|
2020
|
|
Implementing Early Intervention Services for Clinical High Risk for Psychosis in U.S. Community Settings: What Do We Know and What Do We Need to Know?
|
Meeting/ Workshop
|
SAMHSA
|
NIMH
|
2016
|
|
Improving Genomics/Omics Technical Standards and Molecular Tools for Prebiotic Probiotic Research and Development Working Group
|
Research Initiative
|
CDC, FDA, OS
|
NCCIH, NCI, NHGRI, NIDA, NLM
|
2016
|
|
Improving Steps in the Development and Assessment of Live Microbiome-Based Products: Fecal Microbiota for Transplantation (FMT) and Live Biotherapeutic Products (LBPs)
|
Resource Development
|
FDA
|
NIAID
|
2019
|
|
In Vitro Assessment of Dermal Hypersensitivity: Using Alternative Methods to Predict Skin Sensitization
|
Research Initiative
|
FDA
|
NIEHS
|
2018
|
|
Inclusion Across the Lifespan
|
Meeting/ Workshop
|
FDA
|
NCI, NHLBI, NIA, NICHD, NIDCR, NIMHD, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH, OD/ OER
|
2016
|
|
Incorporating a Sex-and Gender Lens from Bench to Bedside: Neurology
|
Meeting/ Workshop
|
FDA
|
OD/ DPCPSI/ ORWH
|
2020
|
|
Industrywide exposure assessment study of workers exposed to graphene and other two-dimensional nanomaterials
|
Research Initiative
|
CDC
|
NIEHS
|
2018
|
|
Influenza Diagnostics Risk Management Meeting (FRMM) Strategy Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC, FDA
|
NIAID
|
2018
|
|
Influenza Risk Management Meeting
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2007
|
|
Inter-Agency Working Group on the National Healthcare Quality and Disparities Report
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, HRSA, IHS, OS
|
NCI, NHLBI, NIMHD, OD/ DPCPSI
|
2015
|
|
Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG)
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA
|
CC, NCATS, NCI, NEI, NHGRI, NHLBI, NIAAA, NICHD, NLM
|
2013
|
|
Interagency Adult Literacy Research Group
|
Committee, Advisory Group, or Work Group
|
ACF
|
NICHD
|
2014
|
|
Interagency Agreement
NTP/NIEHS and NCTR/FDA (IAA)
|
Other
|
FDA
|
NIEHS
|
1993
|
|
Interagency Artificial Pancreas Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIBIB, NICHD, NIDDK
|
2007
|
|
|